BCM
FLXN

Bayesian Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bayesian Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,325
Closed -$224K – 798
2019
Q3 		$224K Buy
16,325
+6,300
+63% +$86.4K 0.04% 424
2019
Q2 		$123K Buy
+10,025
New +$123K 0.03% 455